Cormorant Asset Management, 10% Owner: Ambrx Biopharma AMAM Buy · Filed 23/04/17

Trade details

Type: Insider buy
Amount: $8,385,991.32
Shares · price: 841,967 sh · $9.96 a share
Held after: 61,535,775 sh
Stock: Ambrx Biopharma AMAM
Person: Cormorant Asset Management10% Owner
Trade date: 23/04/14
Filed: 23/04/17
Days to filing: 3 days

4 insiders bought this week

Insiders buying this week: 4 insiders
Holding change: +1.4%

Ambrx Biopharma trades, last 26 weeks

What else happened in Ambrx Biopharma around then

Filed or reported within 30 days of the trade day · 23/03/15~23/05/14

Cormorant Asset Management's recent trades

Cormorant Asset ManagementOther
SellBright Minds Biosciences
Sell
Bright Minds Biosciences
DRUG
$9.8M
109,331 sh
$9.8M
Filed 04/30
Traded 04/28
Cormorant Asset Management10% Owner
SellCorbus Pharmaceuticals Holdings
Sell
Corbus Pharmaceuticals Holdings
CRBP
$344.1K
30,029 sh
$344.1K
Filed 25/12/15
Traded 25/12/11
Cormorant Asset ManagementOther
SellEyePoint
Sell
EyePoint
EYPT
$942K
60,000 sh
$942K
Filed 25/12/08
Traded 25/12/04
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$25.7M
3,390,943 sh
$25.7M
Filed 25/10/01
Traded 25/09/29
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$18.5M
2,800,000 sh
$18.5M
Filed 25/10/01
Traded 25/09/29